例）生活習慣病

放射線治療科 - 業績一覧（著書・論文）

著書

2026

  1. 「乳癌診療ガイドライン2026（金原出版）」分担執筆：清水口　卓也
  2. 「がん放射線治療パーフェクトブック 改訂第2版（Gakken）」分担執筆：伊藤　慶
  3. 「脊椎転移に対する再照射SBRT —標準治療の限界を超える挑戦—（臨床放射線）」執筆：伊藤　慶

2025

  1. 「日本の診断参考レベル（2025年版）（医療被ばく研究情報ネットワーク）」分担執筆：木藤　哲史・須田　雄飛
  2. 「できる看護師のキャリア戦略　迷ったときに読む１００のヒント（Gakken）」分担執筆：田中　陽子

2024

  1. 「放射線治療計画ガイドライン2024（金原出版）」分担執筆：室伏　景子・清水口　卓也・伊藤　慶
  2. 「大腸癌治療ガイドライン2024年版（⾦原出版）」分担執筆：室伏　景子
  3. 「乳癌脳転移に対する治療の概略と高精度放射線治療（乳癌の臨床、篠原出版新社）」執筆：清水口　卓也
  4. 「やさしくわかる放射線治療学 改訂第2版（Gakken）」分担執筆：伊藤　慶

2023

  1. 「がん・放射線療法2023（秀潤社）」分担執筆：室伏　景子 ・木藤　哲史・清水口　卓也・伊藤　慶
  2. 「強度変調放射線治療における物理技術ガイドライン 2023（日本放射線腫瘍学会）」分担執筆：木藤　哲史・須田　雄飛
  3. 「やさしくわかる放射線治療学 改訂第二版（Gakken）」分担執筆：伊藤　慶
  4. 「ライフライン21がんの先進医療　特集　大腸がん-診断と治療　2023年7月50号（蕗書房）」分担執筆：室伏　景子
  5. 「トリプルネガティブ乳癌 Q&A（医歯薬出版）」分担執筆：清水口　卓也
  6. 「乳癌診療 State of the art（医歯薬出版）」分担執筆：清水口　卓也
  7. 「Stereotactic Body Radiation Therapy 2nd Edition: Principles and Practices（Springer）」分担執筆：伊藤　慶 ・中島　祐二朗
  8. 「放射線治療学（南山堂）」分担執筆：伊藤　慶

2022

  1. 「大腸癌治療ガイドライン2022（金原出版）」分担執筆：室伏　景子
  2. 「がん支持医療テキストブック（日本がんサポーティブケア学会）」分担執筆：室伏　景子・田中　陽子・金丸　友樹・須田　雄飛
  3. 「乳癌診療ガイドライン2022（金原出版）」システマティックレビュー委員：清水口　卓也
  4. 「人体のメカニズムから学ぶ放射線治療学（メジカルビュー社）」分担執筆：室伏　景子・木藤　哲史
  5. 「がん性疼痛 薬の使い方（克誠堂出版）」分担執筆：清水口　卓也・伊藤　慶
  6. 「乳癌診療 state of the art（医歯薬出版）」分担執筆：清水口　卓也
  7. 「強度変調放射線治療 治療計画のコツ: 時間をかけずに的確に行う（学研プラス）」分担執筆：伊藤　慶・中島　祐二朗

2021

  1. 「脊椎SBRTパーフェクトガイド －600症例の経験から－（メディカルアイ）」執筆：伊藤　慶・中島　祐二朗
  2. 「レディオミクス入門（オーム社）」分担執筆：中島　祐二朗・阿部　幸太

2020

  1. 「遺伝性大腸癌診療ガイドライン2020（金原出版）」分担執筆：室伏　景子
  2. 「高齢者がん医療Q&A　臓器別編（金原出版）」分担執筆：室伏　景子
  3. 「詳説非剛体レジストレーション-放射線治療領域-（中外医学社）」編集：木藤　哲史、分担執筆：中島　祐二朗

2019

  1. 「Brachytherapy: Techniques and Evidences（Springer）」分担執筆：室伏　景子

2018

  1. 「放射線治療における非剛体画像レジストレーション利用のためのガイドライン2018年版（日本放射線腫瘍学会）」分担執筆：木藤　哲史

2017

  1. 「がん・放射線療法2017（秀潤社）」編著：唐澤　克之、分担執筆：室伏　景子、早川　沙羅
  2. 「肝癌診療ガイドライン2017（金原出版）」実務協力者：清水口　卓也

2016

  1. 「外部放射線治療におけるQAシステムガイドライン2016年版（日本放射線腫瘍学会）」分担執筆：木藤　哲史
  2. 「放射線治療物理学（国際文献社）」分担執筆：木藤　哲史

2015

  1. 「患者さんと家族のための放射線治療Q&A 2015（金原出版）」分担執筆：待鳥　裕美子・早川　沙羅

英文論文

2026

  1. Murofushi K, et al. Outcomes of two or more rounds of hematopoietic stem cell transplantation using total body irradiation for hematological malignancies. Radiother Oncol. 2026.
  2. Ito K, et al. Phase II trial of re-irradiation stereotactic body radiotherapy for painful spinal metastases. Jpn J Clin Oncol. 2026;56(4):428-434.
  3. Suda Y, et al. Comparison of Titanium and Carbon Fiber-Reinforced Polyetheretherketone Spinal Implants in Postoperative Spine Stereotactic Body Radiotherapy: A Comprehensive Review of Current Evidence and Future Perspectives. Adv Radiat Oncol. 2026.
  4. Kaito S, Nakajima Y, et al. Evaluation of a Monte Carlo-based independent dose calculation system for brain stereotactic radiotherapy using a robotic radiosurgery system. Radiol Phys Technol. 2026;19(1):68-76.
  5. Ito S, Nakajima Y, et al. Comparison of Computed Tomography Ventilation Imaging and Hyperpolarized 3He Magnetic Resonance Imaging in Patients With Lung Cancer. Int J Radiat Oncol Biol Phys. 2026.

2025

  1. Murofushi K, et al. Impact of Geriatric Assessment on Radiotherapy Intensity in Older Patients With Nonmetastatic Cancer: A Multi-institutional Study. Clin Oncol. 2025;45:103894.
  2. Murofushi K, et al. Contouring atlas and essential points for radiotherapy in rectal cancer. J Radiat Res. 2025;66(3):203-211.
  3. Ito K, et al. Palliative stereotactic body radiotherapy for spinal and non-spinal bone metastases: combining tradition and innovation. Int J Clin Oncol. 2025;30(8):1492-1499.
  4. Ito K, et al. Contouring compliance and variability of targets and organs at risk in spine stereotactic body Radiotherapy: A 34-Institution study. Radiother Oncol. 2025;207:110877.
  5. Ito K, et al. Pharyngeal mucositis and esophagitis after re-irradiation spine stereotactic body radiotherapy with 24 Gy in two fractions. Clin Transl Radiat Oncol. 2025;57:101100.
  6. Kito S, et al. Imaging dose in image-guided radiotherapy for localized prostate intensity-modulated radiotherapy: a nationwide survey in Japan. J Radiat Res. 2025;67(1):95-104.
  7. Tsurumaki F, Nakajima Y, et al. Optimal combination of collimator angles for dual-arc volumetric modulated arc therapy planning in stereotactic body radiotherapy for spinal metastases. Med Dosim. 2025;50(1):74-79.
  8. Kurosawa S, Murofushi K, et al. Improved non-relapse mortality in allogeneic hematopoietic stem cell transplantation: a long-standing multidisciplinary pursuit at a single center. Bone Marrow Transplant. 2025;60(8):1193-1195.

2024

  1. Kita R, Ito K, et al. Randomized phase III study comparing re-irradiation stereotactic body radiotherapy and conventional radiotherapy for painful spinal metastases: Japan Clinical Oncology Group study JCOG2211 (RESCORE study). Jpn J Clin Oncol. 2025;55(2):189-193. 
  2. Ito K, et al. Phase II Clinical Trial of Second Course of Stereotactic Body Radiotherapy for Spinal Metastases. Cancers (Basel). 2024;16(12):2286.
  3. Ito K, et al. Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy. Jpn J Radiol. 2025;55(2):189-193. 
  4. Ito K, et al. Prophylactic cranial irradiation for limited-stage small-cell lung cancer in the modern magnetic resonance imaging era may be omitted: a propensity score-matched analysis. J Radiat Res. 2024;65(6):805-812.
  5. Ishida T, et al. Proton Beam Therapy for Treating Patients with Hepatocellular Carcinoma with Major Portal Vein Tumor Invasion: A Single Center Retrospective Study. Cancers. 2024;16(11):2050.
  6. Kito S, et al. Population-based asymmetric margins for moving targets in real-time tumor tracking. Med Phys. 2024;51(3):2473-4209.
  7. Kito S, et al. Radiological imaging protection: a study on imaging dose used while planning computed tomography for external radiotherapy in Japan J Radiat Res. 2024;65(2):159-167.

2023

  1. Murofushi K, et al. A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10-2 trial). J Radiat Res. 2023;64(1):154-161.
  2. Murofushi K, et al. Preliminary Study on Establishing a Heart Rate Variability-based Method for Objectively Evaluating Bone Metastasis Pain. In Vivo. 2023;37(2):940-947.
  3. Ito K, et al. Incidence and Prognostic Factors of Painful Vertebral Compression Fracture Caused by Spine Stereotactic Body Radiotherapy. J Clin Med.

2022

  1. Machitori Y, Ito K, et al. Local Control of Stereotactic Body Radiotherapy with Dynamic tumor Tracking for Lung Tumors: A Propensity Score-Matched Analysis. Jpn J Clin Oncol. 2022
  2. Ito K, et al. Phase 2 Clinical Trial of Separation Surgery Followed by Stereotactic Body Radiation Therapy for Metastatic Epidural Spinal Cord Compression. Int J Radiat Oncol Biol Phys. 2022;112(1):106-113.
  3. Ito K, et al. Fracture risk following stereotactic body radiotherapy for long bone metastases. Jpn J Clin Oncol. 2022;52(1):47-52.
  4. Ito K, et al. Accelerated hypofractionated radiotherapy with 3 Gy per fraction for central/ultra-central lung tumors: toxicity to mediastinal organs. Japanese Journal of Clinical Oncology. 2023;53(3):237-244.
  5. Ito K, et al. Stereotactic body radiotherapy versus conventional radiotherapy for painful bone metastases: a systematic review and meta-analysis of randomised controlled trials. Radiation Oncology. 2022;17(1):156.
  6. Ito K, et al. Palliative efficacy of high-dose stereotactic body radiotherapy versus conventional radiotherapy for painful non-spine bone metastases: a propensity score-matched analysis. Cancers (Basel). 2022;14(16):4014.
  7. Ito K, et al. Risk of radiculopathy caused by second course of spine stereotactic body radiotherapy. Japanese Journal of Clinical Oncology. 2022;52(8):911-916.
  8. Ito K, et al. Palliative radiotherapy for multiple liver metastases: a retrospective analysis of 73 cases. Japanese Journal of Clinical Oncology. 2022;52(7):779-784.
  9. Ito K, et al. Stereotactic body radiotherapy for spinal oligometastases: a review on patient selection and the optimal methodology. Japanese Journal of Radiology. 2022;40(10):1017-1023.
  10. Murofushi K, et al. Re-irradiation with interstitial brachytherapy in uterine cancer patients with vaginal recurrence after post-operative pelvic irradiation. Journal of Contemporary Brachytherapy. 2022;14(1):60-65.

2021

  1. Kurokawa M, Shimizuguchi T, et al. Notable response of SMARCA4-deficient undifferentiated uterine sarcoma to palliative radiotherapy. Adv Radiat Oncol. 2021
  2. Ito K, et al. Novel approach involving stereotactic body radiotherapy followed by intramedullary nail placement for long bone metastases: a case report. Clin Exp Metastasis. 2021;38(4):425-427.
  3. Ito K, et al. Electron beam intraoperative radiotherapy for metastatic epidural spinal cord compression: A prospective observational study. Clin Exp Metastasis. 2021;38(2):219-225.
  4. Ito K, et al. Phase 2 clinical trial of stereotactic body radiotherapy for painful non-spine bone metastases. Practical radiation oncology 2021;11(2):e139-e145.
  5. Ito K, et al. Efficacy and toxicity of re-irradiation spine stereotactic body radiotherapy with respect to irradiation dose history. Jpn J Clin Oncol. 2021;51(2):264-270.
  6. Ito K, et al. Stereotactic body radiotherapy for patients with sacral chordoma who previously received carbon ion therapy. Int J Radiation Oncol Biol Phys. 2020;110(5):1263-1264.
  7. Hayakawa S, Ito K, et al. Safety of biliary stent placement followed by definitive chemoradiotherapy in patients with pancreatic cancer with bile duct obstruction. J Gastrointest Oncol. 2021;12(5):2260-2267.
  8. Murofushi K, et al. Risk factors for venous thromboembolism induced by prolonged bed rest during interstitial brachytherapy for gynecological cancer: a retrospective study. Radiation Oncology. 2021;16(1):121.
  9. Murofushi K, et al. Outcomes and dose–volume parameters for computed tomography-based brachytherapy planning for vaginal recurrence of uterine cancer primarily treated with surgery. Clinical and Experimental Obstetrics & Gynecology. 2021;48(3):601-605.
  10. Murofushi K, et al. Impact of pre-brachytherapy magnetic resonance imaging on dose-volume histogram of locally advanced cervical cancer patients treated with radiotherapy including high-dose-rate brachytherapy. Journal of Contemporary Brachytherapy. 2021;13(1):32-38.
  11. Murofushi K, et al. Provisional Clinical Opinions for Radiation Therapy in Prefrail Elderly Colorectal Cancer Patients: Part One. Nippon Daicho Komonbyo Gakkai Zasshi. 2021;74(7):413-421.
  12. Murofushi K, et al. Provisional Clinical Opinions for Radiation Therapy in Prefrail Elderly Colorectal Cancer Patients: Part Two. Nippon Daicho Komonbyo Gakkai Zasshi. 2021;74(7):422-430.
  13. Suda Y, et al. Direct energy spectrum measurement of X-ray from a clinical linac. J Appl Clin Med Phys. 2021;22(8):255-264.

2020

  1. Murofushi K, et al. Outcomes analysis of pre-brachytherapy MRI in patients with locally advanced cervical cancer. Int J Gynecol Cancer 30: 473-479, 2020
  2. Murofushi K, et al. Selection criteria and clinical outcomes of patients with asymmetrical cervical cancer treated with various high-dose-rate brachytherapy techniques. Anticancer Res. 40: 999-1006, 2020
  3. Shimizuguchi T et al. Radiation therapy and the risk of herpes zoster in patients with cancer: Cancer. 126(15):3552-3559, 2020
  4. Shimizuguchi T et al. Stereotactic body radiation therapy for primary liver tumors with adverse factors: Hepatoma Research. 6, 2020
  5. Ito K, et al. Stereotactic body radiotherapy for bone metastases in patients with colorectal cancer. Jpn J Clin Oncol. 2020;50(12):1442-1446.
  6. Ito K, et al. Appropriate endpoints for stereotactic body radiotherapy for bone metastasis: classification into five treatment groups. Rep Pract Oncol Radiother. 2020;25(1):150-153.
  7. Hirota H, Ito K, et al. Safety of Radiotherapy for Hemodialysis Patients with Cancer. Int J Clin Oncol. 2020;25(5):978-983.
  8. Nakajima et al. Evaluation of the effect of user-guided deformable image registration of thoracic images on registration accuracy among users. Med Dosim. 45(3):206-212, 2020
  9. Nakajima et al. Variations Between Dose-Ventilation and Dose-Perfusion Metrics in Radiation Therapy Planning for Lung Cancer. Adv Radiat Oncol. 5(3):459-465, 2020
  10. Konishi T, Ogawa H, et al. Safety of total body irradiation using intensity-modulated radiation therapy by helical tomotherapy in allogeneic hematopoietic stem cell transplantation: a prospective pilot study. J Radiat Res. 2020;61(6):969-976.

2019

  1. Ito K, et al. Whole-liver radiotherapy for diffuse liver metastases improves liver enzymes and related factors. Acta Oncol. 2019;58(4):512-514.
  2. Ito K, et al. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy. Jpn J Clin Oncol. 2019;49(3):270-275.
  3. Ito K, et al. Determining the recommended dose of stereotactic body radiotherapy boost in patients with cervical cancer who are unsuitable for intracavitary brachytherapy: a phase I dose-escalation study. Jpn J Clin Oncol. 2019;49(9):856-861.
  4. Ito K, et al. A prospective multicentre feasibility study of stereotactic body radiotherapy in Japanese patients with spinal metastases. Jpn J Clin Oncol. 2019
  5. Hashimoto S, et al. Energy dependence of a radiophotoluminescent glass dosimeter for HDR 192Ir brachytherapy source. Med Phys. 2019;46(2):964-972.
  6. Furuya T, et al. Feasibility of spine stereotactic body radiotherapy for patients with large tumors in multiple vertebrae undergoing re-irradiation: Dosimetric challenge using 3 different beam delivery techniques. Med Dosim. 2019;44(4):415-420.

2018

  1. Karasawa K, et al. Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up. Technol Cancer Res Treat. 2018
  2. Ito K, et al. Stereotactic Body Radiotherapy for Spinal Metastases: Clinical Experience in 134 cases from a Single Japanese Institution. Technol Cancer Res Treat. 2018
  3. Ito K, et al. Patterns of Intraosseous Recurrence after Stereotactic Body Radiotherapy for Coxal Bone Metastasis. Int J Radiation Oncol Biol Phys, 100(1), 159-161, 2018
  4. Ito K, et al. Postoperative re-irradiation using stereotactic body radiotherapy for metastatic epidural spinal cord compression. Journal of Neurosurgery: Spine. 29(3): 332-338, 2018
  5. Ogawa H, et al. Re-irradiation for painful bone metastases using stereotactic body radiotherapy. Acta Oncol. 2018;57(12):1700-1704.
  6. Hashimoto S, et al. Field-size correction factors of a radiophotoluminescent glass dosimeter for small-field and intensity-modulated radiation therapy beams. Med phys 45(1): 382-390，2018.
  7. Furuya T, et al. Assessing functionality and benefits of comprehensive dose volume prescriptions: An international, multi-institutional, treatment planning study in spine stereotactic body radiation therapy. Pract Radiat Oncol. 2019;9(1):9-15.
  8. Abe K, et al. Impact of a commercially available model-based dose calculation algorithm on treatment planning of high-dose-rate brachytherapy in patients with cervical cancer. J Radiat Res. 59(2):198-206, 2018
  9. Kawamoto T, et al. Clinical outcomes and prognostic factors of chemoradiotherapy for postoperative lymph node recurrence of esophageal cancer. Jpn J Clin Oncol. 48(3): 259-264, 2018
  10. Kawamoto T, et al. Comparison of xerostomia incidence after three-dimensional conformal radiation therapy and contralateral superficial lobe parotid-sparing intensity-modulated radiotherapy for oropharyngeal and hypopharyngeal cancer. Auris Nasus Larynx. 45(5): 1073-1079, 2018
  11. Kawamoto T, et al. Palliative radiotherapy and chemoradiotherapy in stage IVA/B esophageal cancer patients with dysphagia. Int J Clin Oncol. 23(6): 1076-1083, 2018
  12. Kawamoto T, et al. Intensity-modulated radiotherapy for synchronous cancer of the anal canal and cervix. Oncol Lett. 16(4): 4512-4518, 2018
  13. Kawamoto T, et al. Involved-field chemoradiotherapy for postoperative solitary lymph node recurrence of esophageal cancer. Esophagus. 15(4): 256-262, 2018
  14. Kawamoto T, et al. Definitive Radiotherapy for Esophageal Squamous Cell Carcinoma after Allogeneic Hematopoietic Stem Cell Transplantation with Conditioning of Total Body Irradiation. Gan To Kagaku Ryoho. 45(9): 1357-1359, 2018
  15. Kawamoto T, et al. Sacral insufficiency fracture after stereotactic body radiation therapy for sacral metastasis. Clin Case Rep. 6(11): 2293-2294, 2018
  16. Kageyama SI, et al. Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients. Oncotarget. 2018;9(27):19368-19378

2017

  1. Shimizuguchi T, et al. A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer. Int J Clin Oncol. 2017, 22(2), 373–379
  2. Ito K, et al. First report of stereotactic body radiotherapy for large-volume spinal tumor. International Cancer Conference Journal 6(4), 149–153, 2017

2016

  1. Kawamoto T, et al. Intramedullary Spinal Cord Metastasis from Breast Cancer Mimicking Delayed Radiation Myelopathy: Detection With (18)F-FDG PET/CT. Nucl Med Mol Imaging. 50(2): 169-70, 2016

和文論文

2025

  1. 室伏景子．直腸癌の術前化学放射線療法．画像診断 2025;45(7).
  2. 木藤哲史．Japan DRLs 2025改定の概要と活用のポイント:成人治療計画CT．INNERVISION 2025;40(12):20-21.

2024

  1. 室伏景子．肛門管扁平上皮癌に対する化学放射線療法．臨床外科 2024;79(9).
  2. 伊藤慶．体幹部定位放射線治療（SBRT）の適応と効果．脊椎脊髄ジャーナル 2024;37(10).

2023

  1. 室伏景子．老年腫瘍学の現状と将来展望 4．高齢がん患者の放射線療法．日本老年医学会雑誌．
  2. 伊藤慶．転移に対する定位放射線治療．泌尿器外科 2023;36(2):138-143.

2022

  1. 伊藤慶．骨転移に対する定位放射線治療．臨床泌尿器科 2022;76(8):542-545.

2021

  1. 伊藤慶．脊椎転移に対する定位放射線治療－病態に応じた新分類の提案．定位的放射線治療 2021;25: 83-89.
  2. 伊藤慶、中島祐二朗．脊椎SBRTパーフェクトガイド ～600症例の経験から～ Rad Fan.
  3. 伊藤慶、中島祐二朗．脊椎SBRT：エビデンスと方法論．臨床放射線 2021;66(6):555-566.
  4. 中島祐二朗．骨転移SBRTのQA．医学物理 2021;41(1):22-26.

2020

  1. 伊藤慶．定位放射線治療：がんロコモ回避への新たなアプローチ．Bone Joint Nerve（BJN）2020;10(3).

2019

  1. 待鳥裕美子．局所症状を呈するオンコロジーエマージェンシー　頭蓋内転移．内科 2019;124(2):1557-1560.
  2. 伊藤慶．脊椎転移に対する定位放射線治療：実践編．Rad Fan 2019;17(14):58-61.

2018

  1. 唐澤克之．女性における放射線診断ならびに放射線治療による被曝の留意点．胆と膵 2018;39(6):569-573.
  2. 川本晃史．全身照射を用いた同種造血幹細胞移植後に発症した食道癌に対して根治的放射線治療を施行した1例．癌と化学療法 2018;45(9):1357-1359.

2017

  1. 唐澤克之．転移のある甲状腺癌に対する放射線療法．日本内分泌・甲状腺外科学会雑誌 2017;34(4).
  2. 伊藤慶．転移性脊髄圧迫に対する除圧術および定位放射線治療（総説）．脊椎脊髄ジャーナル 2017;30(7):677-681.
  3. 柴田友紀子．89SrCl2（89Sr）による骨転移治療．耳鼻咽喉科・頭頸部外科 2017;89(11).
  4. 古谷智久．脊椎転移に対する体幹部定位放射線治療：高精度治療導入時における当科のプロセス紹介．Rad Fan 2017;15(14):17-21.

2016

  1. 唐澤克之．PSA再発の定義および治療上の問題点．日本臨床 2016;74(3).
  2. 唐澤克之．各種IMRTテクニックと新しい放射線治療機器．医学のあゆみ 2016;257(1):37-41.
  3. 伊藤慶．術後治療としてIMRTを用いて拡大照射を試みた子宮頸癌の1例．東京産科婦人科学会会誌 2016;65(2):296-300.
  4. 伊藤慶．脊椎転移に対する定位放射線治療．Rad Fan 2016;14(14):41-44.

放射線治療科